293 related articles for article (PubMed ID: 4028012)
1. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
Hemminki K
Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
[TBL] [Abstract][Full Text] [Related]
2. N-(2-hydroxyethyl)-N-[2-(7-guaninyl)ethyl]amine, the putative major DNA adduct of cyclophosphamide in vitro and in vivo in the rat.
Benson AJ; Martin CN; Garner RC
Biochem Pharmacol; 1988 Aug; 37(15):2979-85. PubMed ID: 3395373
[TBL] [Abstract][Full Text] [Related]
3. A cyclophosphamide/DNA phosphoester adduct formed in vitro and in vivo.
Maccubbin AE; Caballes L; Riordan JM; Huang DH; Gurtoo HL
Cancer Res; 1991 Feb; 51(3):886-92. PubMed ID: 1988129
[TBL] [Abstract][Full Text] [Related]
4. Identification of phosphoramide mustard/DNA adducts using tandem mass spectrometry.
Cushnir JR; Naylor S; Lamb JH; Farmer PB; Brown NA; Mirkes PE
Rapid Commun Mass Spectrom; 1990 Oct; 4(10):410-4. PubMed ID: 2134189
[TBL] [Abstract][Full Text] [Related]
5. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
6. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
7. DNA-binding products of nornitrogen mustard, a metabolite of cyclophosphamide.
Hemminki K
Chem Biol Interact; 1987 Jan; 61(1):75-88. PubMed ID: 3815587
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
9. Alkylating properties of phosphoramide mustard.
Colvin M; Brundrett RB; Kan MN; Jardine I; Fenselau C
Cancer Res; 1976 Mar; 36(3):1121-6. PubMed ID: 1253171
[TBL] [Abstract][Full Text] [Related]
10. Half-life of oxazaphosphorines in biological fluids.
Sladek NE; Powers JF; Grage GM
Drug Metab Dispos; 1984; 12(5):553-9. PubMed ID: 6149904
[TBL] [Abstract][Full Text] [Related]
11. Interaction of cyclophosphamide with DNA in isolated rat liver cell nuclei.
Lindemann H
Anticancer Res; 1984; 4(1-2):53-8. PubMed ID: 6712177
[TBL] [Abstract][Full Text] [Related]
12. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
Yuan ZM; Smith PB; Brundrett RB; Colvin M; Fenselau C
Drug Metab Dispos; 1991; 19(3):625-9. PubMed ID: 1680629
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic detoxification of phosphoramide mustard by soluble fractions from rat organ tissues.
Hong PS; Chan KK
Drug Metab Dispos; 1991; 19(3):568-73. PubMed ID: 1680621
[TBL] [Abstract][Full Text] [Related]
14. N2 atom of guanine and N6 atom of adenine residues as sites for covalent binding of metabolically activated 1'-hydroxysafrole to mouse liver DNA in vivo.
Phillips DH; Miller JA; Miller EC; Adams B
Cancer Res; 1981 Jul; 41(7):2664-71. PubMed ID: 7248936
[TBL] [Abstract][Full Text] [Related]
15. Analysis and excision of ring-opened phosphoramide mustard-deoxyguanine adducts in DNA.
Chetsanga CJ; Polidori G; Mainwaring M
Cancer Res; 1982 Jul; 42(7):2616-21. PubMed ID: 7083154
[TBL] [Abstract][Full Text] [Related]
16. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
Hales BF
Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat.
Hong PS; Srigritsanapol A; Chan KK
Drug Metab Dispos; 1991; 19(1):1-7. PubMed ID: 1673381
[TBL] [Abstract][Full Text] [Related]
18. Trapping of DNA-reactive metabolites of therapeutic or carcinogenic agents by carbon-14-labeled synthetic polynucleotides.
Mehta JR; Ludlum DB
Cancer Res; 1982 Aug; 42(8):2996-9. PubMed ID: 7093949
[TBL] [Abstract][Full Text] [Related]
19. Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.
Jardine I; Fenselau C; Appler M; Kan MN; Brundrett RB; Colvin M
Cancer Res; 1978 Feb; 38(2):408-15. PubMed ID: 620410
[TBL] [Abstract][Full Text] [Related]
20. Covalent DNA-Protein Cross-Linking by Phosphoramide Mustard and Nornitrogen Mustard in Human Cells.
Groehler A; Villalta PW; Campbell C; Tretyakova N
Chem Res Toxicol; 2016 Feb; 29(2):190-202. PubMed ID: 26692166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
